IAIM
FLNA

International Assets Investment Management’s Filana Therapeutics FLNA Stock Holding History

International Assets Investment Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,225
Closed -$36.1K – 1703
2024
Q3 		$36.1K Buy
+1,225
New +$28.2K ﹤0.01% 1180

Other funds holding FLNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

International Assets Investment Management's FLNA Position: Q4 2024 in Review

International Assets Investment Management sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 1,225 shares — an estimated $36.1K sold.

International Assets Investment Management first reported a position in FLNA in Q3 2024 and held it in 1 quarter. The position peaked at $36.1K in Q3 2024. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • International Assets Investment Management reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • International Assets Investment Management sold 1,225 Filana Therapeutics shares in Q4 2024, an estimated $36.1K.
  • International Assets Investment Management first reported a position in Filana Therapeutics in Q3 2024 and held it in 1 quarter.
  • International Assets Investment Management's Filana Therapeutics position peaked at $36.1K in Q3 2024.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on International Assets Investment Management's 13F filing for Q4 2024, filed 8 Jan 2025.